期刊
THERANOSTICS
卷 8, 期 15, 页码 4238-4246出版社
IVYSPRING INT PUBL
DOI: 10.7150/thno.24387
关键词
Neoantigen; vaccine; immunotherapy; T-cell response
资金
- National Key Research and Development Program of China [2017YFC1308900]
- Key Research and Development Program of Jiangsu Province [BE2017607]
- Jiangsu Provincial Medical Youth Talent [QNRC2016045]
Cancer vaccines have encountered their ideal personalized partner along with evidence for great breakthroughs in the identification and synthesis of neoantigens. Individual cancer neoantigen vaccines are capable of eliciting robust T-cell responses and have been demonstrated to achieve striking clinical efficacy due to their high immunogenicity and central thymic tolerance escape of neoantigens. Two recent phase I clinical trials have provided support for the hypothesis and have heralded a nascent era of personalized vaccines in the field of immunotherapy. This review aims to address the identification of neoepitopes and describes advances made in personalized vaccines. In addition, this review discusses the challenges related to the exploitation of vaccine therapy, and provides potential thoughts for the improvement of vaccine design and applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据